BST-605

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameBST-605
Drug Alias Name2nd generation AGE inhibitors (BioStratum)advanced glycation end-product inhibitors (BioStratum)BST-4997BST-605BST-4996 +[6] 
ClassificationSmall molecules
Mechanisms of ActionAdvanced glycation metabolite synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsDiabetes Complications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiostratum Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNephrogenex IncBiostratum Ab
Active IndicationsN/A
Inactive IndicationsDiabetes Complications

Other Information

ATC CodeN/A
Related LinksN/A